Send feedback

CFB p.Pro369Leu

c.1106C>T · rs200890358 · VCV1531488

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1297 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.308%, sas)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
atypical hemolytic-uremic syndrome

Computational evidence

Protein change
AlphaMissense0.1297likely benign
REVEL0.19benign-leaning
SaProtLLR -8.40tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.39GERP -3.8
Overall
CADD5.99PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.308% South Asian · 280/91,052 alleles
Filtering AF 0.278% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.266%
Overall 0.02% 323/1,612,858 alleles · rare exomes 300/1,460,754 · genomes 23/152,104 · joint denominator
Ancestry group Frequency 1 in
South Asiangrpmax 0.308% 325
Middle Eastern 0.0331% 3,024
Remaining individualsnot grpmax-eligible 0.0224% 4,464
East Asian 0.00446% 22,440
African / African-American 0.00267% 37,478
European (non-Finnish) 0.00195% 51,304

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CFB
Protein
p.Pro369Leu
Coding
c.1106C>T
MANE Select
NM_001710
dbSNP
rs200890358
Type
single nucleotide variant
Location
chr6:31948899 (GRCh38)
Gene constraint
LOEUF 0.719 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 86.54 · 28 PDB
Residue 369
a β-strand; the vwfa domain
Full CFB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

atypical hemolytic-uremic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Atypical hemolytic uremic syndrome (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (United States)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfb-p-pro369leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown